MET and cancer: With regard to the immune status of the model, a major advantage of using an immunocompromised model in the current study is that we have been able to demonstrate specific effects of HGF inhibition and c-MET inhibition on human cancer cells and human PSCs, thereby increasing the translational potential of the findings.